Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Constellation Pharmaceuticals stock | $19.81

Learn how to easily invest in Constellation Pharmaceuticals stock.

Constellation Pharmaceuticals Inc is a biotechnology business based in the US. Constellation Pharmaceuticals shares (CNST) are listed on the NASDAQ and all prices are listed in US Dollars. Constellation Pharmaceuticals employs 154 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Constellation Pharmaceuticals

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CNST – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Constellation Pharmaceuticals stock price (NASDAQ: CNST)

Use our graph to track the performance of CNST stocks over time.

Constellation Pharmaceuticals shares at a glance

Information last updated 2021-09-12.
Latest market close$19.81
52-week range$18.10 - $39.30
50-day moving average $33.82
200-day moving average $28.33
Wall St. target price$40.71
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.04

Buy Constellation Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Constellation Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Constellation Pharmaceuticals price performance over time

Historical closes compared with the close of $19.81 from 2021-05-28

1 week (2021-10-15) N/A
1 month (2021-09-22) N/A
3 months (2021-07-22) N/A
6 months (2021-04-26) -11.96%
1 year (2020-10-26) -13.19%
2 years (2019-10-25) 42.31%
3 years (2018-10-26) 211.48%
5 years (2016-10-22) N/A

Constellation Pharmaceuticals financials

Gross profit TTM $0
Return on assets TTM -22.41%
Return on equity TTM -40.7%
Profit margin 0%
Book value $7.88
Market capitalisation $1.6 billion

TTM: trailing 12 months

Shorting Constellation Pharmaceuticals shares

There are currently 2.5 million Constellation Pharmaceuticals shares held short by investors – that's known as Constellation Pharmaceuticals's "short interest". This figure is 28.4% down from 3.5 million last month.

There are a few different ways that this level of interest in shorting Constellation Pharmaceuticals shares can be evaluated.

Constellation Pharmaceuticals's "short interest ratio" (SIR)

Constellation Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Constellation Pharmaceuticals shares currently shorted divided by the average quantity of Constellation Pharmaceuticals shares traded daily (recently around 3.3 million). Constellation Pharmaceuticals's SIR currently stands at 0.76. In other words for every 100,000 Constellation Pharmaceuticals shares traded daily on the market, roughly 760 shares are currently held short.

However Constellation Pharmaceuticals's short interest can also be evaluated against the total number of Constellation Pharmaceuticals shares, or, against the total number of tradable Constellation Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Constellation Pharmaceuticals's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Constellation Pharmaceuticals shares in existence, roughly 50 shares are currently held short) or 0.0774% of the tradable shares (for every 100,000 tradable Constellation Pharmaceuticals shares, roughly 77 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Constellation Pharmaceuticals.

Find out more about how you can short Constellation Pharmaceuticals stock.

Constellation Pharmaceuticals share dividends

We're not expecting Constellation Pharmaceuticals to pay a dividend over the next 12 months.

Constellation Pharmaceuticals share price volatility

Over the last 12 months, Constellation Pharmaceuticals's shares have ranged in value from as little as $18.1 up to $39.3. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Constellation Pharmaceuticals's is 2.5804. This would suggest that Constellation Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Constellation Pharmaceuticals overview

Constellation Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, discovers and develops therapeutics to address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance. The company's lead product candidates include Pelabresib that is in Phase 3 clinical trials for the treatment of patients with myelofibrosis in combination with ruxolitinib. It is also developing CPI-0209 that is in Phase 1 dose escalation portion of a Phase 1/2 clinical trial to treat solid tumors; and CPI-482, which is in preclinical stage for cancer patients. The company was formerly known as Epigenetix, Inc. and changed its name to Constellation Pharmaceuticals, Inc. in March 2008.

Constellation Pharmaceuticals in the news

There are no recent company news

Frequently asked questions

What percentage of Constellation Pharmaceuticals is owned by insiders or institutions?
Currently 1.528% of Constellation Pharmaceuticals shares are held by insiders and 109.699% by institutions.
How many people work for Constellation Pharmaceuticals?
Latest data suggests 154 work at Constellation Pharmaceuticals.
When does the fiscal year end for Constellation Pharmaceuticals?
Constellation Pharmaceuticals's fiscal year ends in December.
Where is Constellation Pharmaceuticals based?
Constellation Pharmaceuticals's address is: 215 First Street, Cambridge, MA, United States, 02142
What is Constellation Pharmaceuticals's ISIN number?
Constellation Pharmaceuticals's international securities identification number is: US2103731061
What is Constellation Pharmaceuticals's CUSIP number?
Constellation Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 210373106

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site